Gene expression profile analysis from the NanoString Cancer Metabolism panel showed a significant decrease in ODC1 and an increase in TSC2 mRNA expression in LCC9 xenografts when these were co-treated with CB-839 and everolimus. Here, ODC1 is linked to cancer.